Investing.com -- Anthropic is close to securing a new funding round of up to $5 billion that would value the artificial intelligence startup at $170 billion, according to Bloomberg.

Hims & Hers, which markets compounded versions of semaglutide through its telehealth platform, released clinical data shortly after Novo’s statement. The data showed that users of its compounded GLP-1 ...

While stablecoins currently make up just 7% of the crypto market, BlackRock noted adoption has grown rapidly to around $250 ...

Investing.com -- The U.S. Food and Drug Administration is recommending that the Drug Enforcement Administration classify the 7-OH compound as a controlled substance, FDA Commissioner Marty Makary ...